Pharmafile Logo
Pharmafocus logo
Advanced Search

Cannabidiol gains MHRA approval as adjunctive treatment of seizures

August 11, 2021
Research and Development

GW Pharmaceuticals has announced that is has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for …

News
andrei_r_-_shutterstock_1935537274_720

Janssen’s MS treatment Ponvory is granted UK marketing authorisation

August 11, 2021
Research and Development

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Marketing Authorisation in Great Britain for PONVORY (ponesimod) for the …

News

Sputnik V vaccine 13% less effective against Delta than originally reported

August 11, 2021
Medical Communications, Research and Development

Russian health officials have announced that the Sputnik V COVID vaccine is 83% effective against the Delta variant on Wednesday, …

News
cdc-un8tv9pw2ik-unsplash_1

More than 75% of UK adults have been double jabbed

August 11, 2021
Research and Development

More than 75% of adults living in the UK have now received both doses of the vaccine, as announced by …

News

Moderna and Canada to collaborate on mRNA manufacturing

August 11, 2021
Manufacturing and Production, Research and Development

Moderna will build a messenger RNA (mRNA) vaccine manufacturing facility in Canada, which will include access to Moderna’s mRNA development …

News
gilead-sciences

Kite receives positive recommendation from SMC for CAR T therapy

August 10, 2021
Manufacturing and Production, Research and Development

Kite has announced a positive recommendation from the Scottish Medicines Consortium (SMC) on the company’s Healthcare Technology Assessment for Tecartus, …

News
laboratory-testing-az

Researchers develop injectable hydrogel to combat Parkinson’s

August 10, 2021
Medical Communications, Research and Development

An Australian research team has developed a hydrogel that can be used as a one-off intervention to treat Parkinson’s disease, …

News

AI system may be able to detect dementia in a day

August 10, 2021
Manufacturing and Production, Medical Communications, Research and Development

Researchers from Cambridge University and The Alan Turing Institute have developed an artificial intelligence (AI) system that can diagnose dementia …

News

Moderna could offer better defence against Delta variant than Pfizer

August 10, 2021
Manufacturing and Production

Pfizer-BioNTech’s mRNA could be less effective than Moderna’s against the Delta variant of COVID-19. In a study of more than …

News
pfizer_building_logo2_1

Scotland approves Merck and Pfizer’s Bavencio for bladder cancer

August 10, 2021
Manufacturing and Production

Merck and Pfizer’s Bavencio (avelumab) has been approved by approved by the Scottish Medicines Consortium (SMC) for use via NHS …

News

Researchers develop new method to kill bacteria on medical implants

August 9, 2021
Medical Communications, Research and Development, Sales and Marketing

Researchers from Chalmers University of Technology, Sweden, have developed a new method to prevent bacterial infections relating to medical implants …

News

‘Potential’ link between vaccines and menstruation changes

August 9, 2021
Sales and Marketing

France’s health body has said changes in women’s menstrual cycles are a “potential” side effect of receiving the Moderna or …

News

Psoriasis treatment bimekizumab maintains high Levels of skin clearance

August 9, 2021
Sales and Marketing

New two-year data has shown that bimekizumab maintained high Levels of skin clearance in patients with moderate to severe plaque …

News
az

First new adult CDK treatment in 20 years gains UK and EU approval

August 9, 2021
Medical Communications, Research and Development, Sales and Marketing

AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …

News

FDA approves Nexviazyme as treatment for late-onset Pompe disease

August 9, 2021
Sales and Marketing

The FDA has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset …

News
az

Sierra Oncology to licence myelofibrosis candidate from AstraZeneca

August 6, 2021
Medical Communications, Research and Development, Sales and Marketing

Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …

News
biktarvy-descovy-bottles

Gilead warns of counterfeit HIV medication being distributed in US

August 6, 2021
Medical Communications

Gilead have released a statement warning of tampered and counterfeit versions of its once-daily single tablet HIV treatment regimen Biktarvy …

News
sanofi_hq__boetie_hall_small_

Libtayo Phase III Trial stopped early due to significant improvement in overall survival

August 6, 2021
Medical Communications

The Phase III trial of Sanofi and Regeneron’s PD-1 inhibitor Libtayo in combination with platinum-doublet chemotherapy was stopped early due …

News

FDA grants Orphan Drug Designation to sotigalimab for soft tissue sarcoma

August 6, 2021
Medical Communications

The FDA has granted Apexigen’s sotigalimab (APX005M) Orphan Drug Designation for the treatment of soft tissue sarcoma.Sotigalimab, Apexigen’s lead therapeutic …

News

Cholesterol pill could cut COVID infections by up to 70%, study finds

August 6, 2021
Medical Communications, Research and Development

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce COVID infections by …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026